---
figid: PMC8324353__BMRI2021-6613439.006
figtitle: Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular
  Carcinoma by Targeting the DNA Damage Pathway
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8324353
filename: BMRI2021-6613439.006.jpg
figlink: /pmc/articles/PMC8324353/figure/fig6/
number: F6
caption: Schematic representation of the antitumor mechanism of the lenvatinib-alisertib
  combination in HCC. Alisertib, a novel AURKA inhibitor that affects the DNA damage
  pathway and its downstream signaling, induces hepatocellular carcinoma cell death
  together with lenvatinib.
papertitle: Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular
  Carcinoma by Targeting the DNA Damage Pathway.
reftext: Jianwen Hao, et al. Biomed Res Int. 2021;2021:6613439.
year: '2021'
doi: 10.1155/2021/6613439
journal_title: BioMed Research International
journal_nlm_ta: Biomed Res Int
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9558558
figid_alias: PMC8324353__F6
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8324353__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8324353__BMRI2021-6613439.006.html
  '@type': Dataset
  description: Schematic representation of the antitumor mechanism of the lenvatinib-alisertib
    combination in HCC. Alisertib, a novel AURKA inhibitor that affects the DNA damage
    pathway and its downstream signaling, induces hepatocellular carcinoma cell death
    together with lenvatinib.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ssb
  - Cdc25b
  - Cdc25c
  - Atr
  - Mmab
  - Brca2
  - Brca1
  - Cdc25a
  - Gabrg2
  - Atm
  - Tpm1
  - Chek2
  - Trp53
  - SSB
  - CDC25B
  - CDC25C
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - BRCA2
  - BRCA1
  - CDC25A
  - WARS1
  - ATM
  - CHEK2
  - TP53
  - TP63
  - TP73
---
